This is a Retrospective Study on the Use of CENOBAMATE as Adjunctive Treatment in Patients Suffering From Epilepsy in Early Access Program in Germany, France and UK
Clinical trial NCT05747001 · COMPLETED
Trial details
- NCT number
- NCT05747001
- Sponsor
- Aziende Chimiche Riunite Angelini Francesco S.p.A
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-27
- Primary completion
- 2023-09-30
- Enrollment
- 319
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.